首页> 美国卫生研究院文献>Nuclear Medicine and Molecular Imaging >Langerhans’ Cell Histiocytosis Masquerading as Metastatic Papillary Thyroid Cancer on F-18 FDG PET/CT: Diagnostic Dilemma Solved by PET/CT-Guided Biopsy
【2h】

Langerhans’ Cell Histiocytosis Masquerading as Metastatic Papillary Thyroid Cancer on F-18 FDG PET/CT: Diagnostic Dilemma Solved by PET/CT-Guided Biopsy

机译:朗格汉斯细胞组织细胞增生症伪装成F-18 FDG PET / CT转移性乳头状甲状腺癌:PET / CT引导活检解决了诊断难题

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

We present a case of papillary thyroid cancer (post-thyroidectomy status) on regular treatment with suppressive Levothyroxine therapy. On follow-up at 6 months after radioactive iodine ablation for remnant thyroid tissue, her thyroglobulin, and anti-thyroglobulin levels were 0.06 ng/ml and 670 IU/ml, respectively. Low-dose whole-body I-131 scan was negative. To look for the cause of isolated increased anti-thyroglobulin level, a whole-body 18F-FDG PET/CT was done which revealed multiple FDG-avid lytic skeletal lesions suggestive of metastases. For confirmation of diagnosis, 18F-FDG PET/CT-guided metabolic biopsy was done, which revealed Langerhans’ cell histiocytosis on histopathological examination.
机译:我们提出了一例甲状腺乳头状癌(甲状腺切除术后的状态),在常规治疗中应用左甲状腺素抑制治疗。放射性碘消融后残留甲状腺组织的6个月随访时,其甲状腺球蛋白和抗甲状腺球蛋白水平分别为0.06 ng / ml和670 IU / ml。小剂量全身I-131扫描呈阴性。为了寻找单独的抗甲状腺球蛋白水平升高的原因,进行了全身 18 F-FDG PET / CT检查,发现存在多个FDG-avid溶血性骨骼病变提示转移。为了确定诊断,进行了 18 F-FDG PET / CT引导的代谢活检,这在组织病理学检查中显示了朗格汉斯的细胞组织细胞增生。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号